Assessment of somatostatin receptor expression in predicting results of PRRT (peptide receptor radionuclide therapy) in disseminated neuroendocrine tumours (NET)

被引：0

作者：

Hubalewska-Dydejayk, Alicja B. ^{[1
]}

Sowa-Staszczak, Anna ^{[1
]}

Trofimiuk, Malgorzata ^{[1
]}

Stefanska, Agnieszka ^{[1
]}

Wierzchowski, Wojciech ^{[2
]}

Kunikowska, Jolanta ^{[3
]}

Pach, Dorota ^{[1
]}

Tomaszewska, Romana ^{[2
]}

机构：

[1] Jagiellonian Univ, Coll Med, Nucl Med Unit, Dept Endocrinol, Krakow, Poland

[2] Jagiellonian Univ, Coll Med, Dept Pathol, Krakow, Poland

[3] Med Univ, Dept Nucl Med, Warsaw, Poland

来源：

ENDOCRINE JOURNAL | 2010年 / 57卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S443 / S443

页数：1

共 50 条

[1] Assessment of Somatostatin Receptors Expression in Predicting Results of Peptide Receptor Radionuclide Therapy (PRRT) in Neuroendocrine Tumours (NET)
Sowa-Staszczak, A.
Trofimiuk, M.
Stefanska, A.
Wierzchowski, W.
Kunikowska, J.
Mikolajczak, R.
Pawlak, D.
Pach, D.
Tomaszewska, R.
Krolicki, L.
Hubalewska-Dydejczyk, A.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S418 - S418
[2] Peptide receptor radionuclide therapy (PRRT) of neuroendocrine tumors with somatostatin analogues
Bodei, L.
Pepe, G.
Paganelli, G.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2010, 14 (04) : 347 - 351
[3] Evaluation of toxicity in peptide receptor radionuclide therapy (PRRT) for neuroendocrine tumors (NET)
Duan, H.
Ferri, V.
Kunz, P. L.
Fisher, G. A.
Moradi, F.
Davidzon, G. A.
Franc, B. L.
Iagaru, A. H.
Mari, C. Aparici
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S471 - S472
[4] Evaluation of Toxicity in Peptide Receptor Radionuclide Therapy (PRRT) for Neuroendocrine Tumors (NET)
Duan, H.
Girod, B.
Ninatti, G.
Ferri, V
Kunz, P.
Fisher, G.
Moradi, F.
Davidzon, G.
Franc, B.
Lagaru, A.
Aparici, Mari C.
NEUROENDOCRINOLOGY, 2020, 110 : 252 - 252
[5] Predicting the outcome of Peptide Receptor Radionuclide Therapy (PRRT) for the treatment of neuroendocrine tumours using PET-CT
Houghton, K.
Carroll, M. J.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S235 - S236
[6] Peptide receptor radionuclide therapy of neuroendocrine tumours
Bodei, L.
Giammarile, F.
MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2009, 33 (03): : 142 - 147
[7] Peptide receptor radionuclide therapy of neuroendocrine tumours
Brabander, Tessa
Teunissen, Jaap J. M.
Van Eijck, Casper H. J.
Franssen, Gaston J. H.
Feelders, Richard A.
de Herder, Wouter W.
Kwekkeboom, Dik J.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 30 (01) : 103 - 114
[8] Peptide receptor radionuclide therapy for neuroendocrine tumours
Siraj Yusuf
Shahad Alsadik
Adil AL-Nahhas
Clinical and Translational Imaging, 2018, 6 : 101 - 111
[9] PEPTIDE RECEPTOR RADIONUCLIDE THERAPY OF NEUROENDOCRINE TUMOURS
Bodei, L.
Grana, C. M.
Cremonesi, M.
Paganelli, G.
ANNALS OF ONCOLOGY, 2012, 23 : 47 - 47
[10] Peptide receptor radionuclide therapy for neuroendocrine tumours
Yusuf, Siraj
Alsadik, Shahad
Al-Nahhas, Adil
CLINICAL AND TRANSLATIONAL IMAGING, 2018, 6 (02) : 101 - 111

← 1 2 3 4 5 →